CD8+ T cells are known to have the ability to directly eliminate tumor cells, making them the preferred immune cells for targeting tumors (Farhood et al., 2019), However, in order to achieve effective anti-tumor immunity, the complementary CD4+ T cells are also necessary (Ahrends et al., 2017). This evidence concerns the gene CD8A and neoplasm.